Anti-hormonal Therapie With or Without Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer
Condition: Breast Cancer Metastatic Interventions: Drug: Ribociclib; Drug: Anastrozole; Drug: Letrozole; Drug: Exemestane; Drug: Fulvestrant; Drug: Tamoxifen Sponsor: German Breast Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials